CVS Health announced a strategic separation of its retail pharmacy division from insurance and PBM operations by 2028. This decision reverses previous vertical integration strategies within the healthcare conglomerate. The move may reshape valuation metrics for healthcare services, potentially benefiting pure-play pharmacy chains while altering competitive dynamics in the PBM space. For CVS, this aims to unlock shareholder value but introduces execution risks during the transition period. Operational focus will shift towards distinct business models rather than integrated care delivery.
4 articles
CVS Health announced plans to separate its retail pharmacy business from its insurance and pharmacy benefit operations by early 2028, unwinding years of expansion into a $117 billion healthcare conglo
CVS Health announced plans to split into two separate companies by 2028, separating retail pharmacy from insurance and pharmacy-benefit management operations amid regulatory scrutiny.
CVS Health plans to split its retail pharmacy business from its insurance and pharmacy-benefit operations, reversing its integrated healthcare strategy amid regulatory scrutiny over the drug supply ch
CVS Health agreed to pay $315 million to resolve DOJ allegations of unlawfully filling unnecessary opioid prescriptions. The settlement mandates new safeguards to monitor controlled substance dispensi
ChemBrief